Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Analysis of cascade impactor mass distributions.

Craig Dunbar1, Jolyon Mitchell

  • 1Alkermes, Inc., 88 Sidney St., Cambridge, Massachusetts 02139, USA. craig.dunbar@alkermes.com

Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
|December 29, 2005
PubMed
Summary

Analyzing cascade impactor (CI) data for pulmonary drug products requires careful method selection. Continuous analysis of aerodynamic diameter provides the most comprehensive mass distribution insights for drug delivery and deposition modeling.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS).

AAPS PharmSciTech·2020
Same author

Reflections on Digital Health Tools for Respiratory Applications.

Journal of aerosol medicine and pulmonary drug delivery·2020
Same author

Innovative preclinical models for pulmonary drug delivery research.

Expert opinion on drug delivery·2020
Same author

Development of a novel digital breath-activated inhaler: Initial particle size characterization and clinical testing.

Pulmonary pharmacology & therapeutics·2018
Same author

Laboratory Study Comparing Pharmacopeial Testing of Nebulizers with Evaluation Based on Nephele Mixing Inlet Methodology.

AAPS PharmSciTech·2017
Same author

A Comparison of the Performance of Efficient Data Analysis Versus Fine Particle Dose as Metrics for the Quality Control of Aerodynamic Particle Size Distributions of Orally Inhaled Pharmaceuticals.

AAPS PharmSciTech·2016

Area of Science:

  • Pharmaceutics
  • Aerosol Science
  • Drug Delivery

Background:

  • Cascade impactors (CI) are crucial for characterizing pulmonary drug product aerosolization.
  • Analyzing CI data is essential for understanding particle size distribution and respiratory tract deposition.
  • Various analytical approaches exist, each with limitations in information richness.

Purpose of the Study:

  • To review cascade impactor (CI) mass distribution analysis methods for pulmonary drug products.
  • To guide the selection of appropriate data analysis procedures for CI data.
  • To highlight considerations for interpreting CI mass distributions in relation to aerodynamic diameter.

Main Methods:

  • Review of existing methods for analyzing CI data, categorizing them by nominal, ordinal, and continuous variables.

Related Experiment Videos

  • Evaluation of the information hierarchy provided by each analysis approach.
  • Discussion of the relationship between mass distribution and aerodynamic diameter.
  • Main Results:

    • Nominal analysis offers a simple overview of emitted mass but lacks aerodynamic diameter correlation.
    • Ordinal analysis introduces stage size ranges, but estimations of in vivo deposition can be inaccurate.
    • Continuous analysis directly relates mass distribution to aerodynamic diameter, enabling product comparison and deposition modeling.

    Conclusions:

    • Continuous analysis of aerodynamic diameter is the most informative method for CI data from pulmonary drug products.
    • Understanding the limitations of each analysis method is critical for accurate interpretation.
    • CI measurement technique limitations, not analysis procedures, affect total emitted mass assessment.